Doma Biopharmaceutical Funding: $134M Raised, Series A

Doma Biopharmaceutical has raised $134M in total funding. Latest round: Series A. Backed by Biocytogen, China Life Private Equity Investment, PICC Capital.

Doma Biopharmaceutical funding overview

Doma Biopharmaceutical has raised $134M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for Doma Biopharmaceutical runs through 2022; nothing later has been disclosed. Investors on record include Biocytogen, China Life Private Equity Investment, PICC Capital, Suzhou Industrial Park Hefeng Capital, Taiping Healthcare Fund, CMB International and 1 others. 7 distinct backers are named across the disclosed rounds.

Doma Biopharmaceutical at a glance

Total raised
$134M
Latest round
Series A
Latest round date
June 2022
Notable investors
Biocytogen, China Life Private Equity Investment, PICC Capital, Suzhou Industrial Park Hefeng Capital, Taiping Healthcare Fund, CMB International, SDIC Venture Capital

Frequently asked about Doma Biopharmaceutical funding

How much has Doma Biopharmaceutical raised?
Doma Biopharmaceutical has raised $134M in total disclosed funding across the rounds on record.
Who has invested in Doma Biopharmaceutical?
Biocytogen, China Life Private Equity Investment, PICC Capital, Suzhou Industrial Park Hefeng Capital, Taiping Healthcare Fund, CMB International are named among the investors backing Doma Biopharmaceutical.
What was the latest Doma Biopharmaceutical funding round?
The most recent disclosed round is a Series A, announced in June 2022.
Where is Doma Biopharmaceutical based?
No headquarters location is disclosed for Doma Biopharmaceutical.
When did Doma Biopharmaceutical last raise?
The last disclosed Doma Biopharmaceutical round closed in June 2022 at Series A.

Doma Biopharmaceutical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Companies related to Doma Biopharmaceutical (30)

Browse related funding lists (4)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades